Mol Neurobiol. 2025 Nov 21;63(1):120.doi: 10.1007/s12035-025-05356-9.
2025-01-12Mol Neurobiol. 2025 Nov 21;63(1):120.doi: 10.1007/s12035-025-05356-9. Fluvoxamine Attenuates Blood-Brain Barrier Disruption in Drug-Resistance Epilepsy and inhibits Ferroptosis via the Sigma-1 Receptor-TAMM41 signaling in bEnd.3 cells 氟伏沙明可减轻耐药性癫痫中的血脑屏障破坏,并通过Sigma-1受体-TAMM41信号通路抑制bEnd.3细胞中的铁死亡